ODPRN_Research Profile Banner
ODPRN Profile
ODPRN

@ODPRN_Research

Followers
2K
Following
3K
Media
965
Statuses
4K

The Ontario Drug Policy Research Network provides timely, high quality drug policy research impacting societal outcomes & improving healthcare systems

Ontario, Canada
Joined August 2013
Don't wanna be here? Send us removal request.
@ODPRN_Research
ODPRN
5 months
NEW ODPRN report examined overall and Safer Opioid Supply (SOS)-related hydromorphone dispensing among Public Health Units (PHUs) in Ontario. We found hydromorphone dispensing—especially for SOS—varied widely across Ontario's PHUs. https://t.co/RL3xVXh0yj #SaferSupply
0
1
3
@ODPRN_Research
ODPRN
5 months
TODAY AT 12:00PM ET! Join us for this engaging conversation on pharmacists prescribing medications for minor ailments in Ontario! https://t.co/05vuXwfyxb
@ODPRN_Research
ODPRN
6 months
Want to learn more about pharmacist prescribing for minor ailments — or have you used it and want to share your experience? Don’t miss this engaging conversation with pharmacist @Mina__T 📅June 17 , 12:00–1:30 PM Reserve your spot: https://t.co/F6T8vuimwp @MAP_Health
0
1
3
@ODPRN_Research
ODPRN
5 months
May data on #opioid-related deaths in #Ontario from the OCC is now available. 🚨In the past 3 months, there were 633 suspect drug-related deaths in Ontario. Data available for download at
Tweet card summary image
odprn.ca
The Office of the Chief Coroner (OCC) for Ontario provides death investigations and inquests to ensure that no death will be overlooked, concealed or ignored. This includes updated summaries of...
0
1
2
@ODPRN_Research
ODPRN
6 months
Interested in pharmacists prescribing for minor ailments? Join the conversation to learn more, hear from others, or share your own experience on how the process could be improved! 📅June 17, 2025 🕰️ 12:00 - 1:30pm EDT https://t.co/mMwjkpeLeW
0
0
1
@Filtermag_org
Filter | harm reduction journalism
6 months
For people starting safe supply, median time to discontinuation was 268 days—versus 103 days for those on methadone, according to a groundbreaking Ontario study. This difference contributed to equal benefits by most measures. Maddi Dellplain reports: https://t.co/OEyWn9O4f8
Tweet card summary image
filtermag.org
Safe supply improved most health outcomes for people who use opioids as effectively as methadone, found a new study out ...
0
10
11
@ODPRN_Research
ODPRN
6 months
News article features OCC data from the ODPRN showing that Thunder Bay continues to have the highest opioid-related death rate in Ontario @RCInet
Tweet card summary image
ici.radio-canada.ca
Thunder Bay consistently reports high opioid-related mortality rates in Ontario.
2
0
1
@ODPRN_Research
ODPRN
6 months
New ODPRN study highlights the rising impact of substance combinations in toxicity-related deaths, along with missed opportunities for intervention and appropriate care. https://t.co/IHrCK2Xekv
1
2
0
@ODPRN_Research
ODPRN
6 months
Want to learn more about pharmacist prescribing for minor ailments — or have you used it and want to share your experience? Don’t miss this engaging conversation with pharmacist @Mina__T 📅June 17 , 12:00–1:30 PM Reserve your spot: https://t.co/F6T8vuimwp @MAP_Health
1
3
2
@ODPRN_Research
ODPRN
6 months
The OCC data available on the ODPRN website shows 4 northern Ontario cities rank among the top 10 in the province for the highest per-capita rates of fatal drug overdoses in 2024. @CTVNewsNorthern https://t.co/9CMU0sSIUw
Tweet card summary image
ctvnews.ca
Northern Ontario cities top fatal overdose rates in the province – with local user citing pain and lack of treatment options among reasons.
2
0
0
@CCSACanada
CCSA
6 months
We sought insights from young people in Canada about how to prevent and reduce youth substance use and related harms. They shared their truths, and now it’s time to tailor our prevention strategies. Read the report here👉 https://t.co/aDDDl0ZvMx
0
1
2
@ODPRN_Research
ODPRN
6 months
Quarterly summaries of opioid-related deaths in Ontario have been updated with 2024 Q4 data. CSDs with the highest mortality rates in 2024 include Thunder Bay, Sault Ste. Marie, and Timmins. Data is available for download at https://t.co/FSCKHAPqIw
0
0
0
@ODPRN_Research
ODPRN
6 months
New global study finds wide variation in opioid use during pregnancy across countries, but similar patterns by sociodemographic and pregnancy characteristics. https://t.co/xOdB45hLu4 @Tara_Gomes @AlysHavard
0
0
0
@ODPRN_Research
ODPRN
6 months
April data on #opioid-related deaths in #Ontario from the OCC is now available. 🚨In the past 3 months, there were 623 suspect drug-related deaths in Ontario. Data available for download at https://t.co/FSCKHAPqIw
1
0
0
@ODPRN_Research
ODPRN
6 months
In case you missed it: This ODPRN study found that BOTH Safer Opioid Supply (SOS) & methadone improve health outcomes and play important complementary roles in responding to Canada’s drug toxicity crisis. Learn more at: https://t.co/L4z9v1Ved2 #HarmReduction #SaferSupply
0
0
1
@ODPRN_Research
ODPRN
6 months
Want to learn more about pharmacist prescribing for minor ailments — or have you used it and want to share your experience? Don’t miss this engaging conversation with pharmacist @Mina__T 📅June 17 , 12:00–1:30 PM Reserve your spot: https://t.co/F6T8vuimwp @MAP_Health
1
3
2
@ODPRN_Research
ODPRN
7 months
The EMS opioid response dashboard has been updated on the Ontario Opioid Indicator Tool with new Q3 2024 data. Overall, the rate of suspected opioid toxicities treated by EMS in Ontario increased, though trends varied by geographic area. https://t.co/lRHC3v0We3
2
0
0
@ODPRN_Research
ODPRN
7 months
New research finds that integrated #treatment programs for #pregnant and parenting people with substance use provide wraparound, gender-sensitive care. Retention in these programs was 4 to 5 times longer compared to standard treatment. https://t.co/V4ZfXm1K4n #substanceuse
0
0
1
@ODPRN_Research
ODPRN
7 months
ODPRN researcher @Tara_Gomes talks with @globalnews about our new study that compares the effects of prescribed safer opioid supply and methadone in Ontario, Canada. https://t.co/QD3AYIdoYp
0
1
4
@ODPRN_Research
ODPRN
7 months
This increase was largely due to expensive small-molecule targeted therapies and immunotherapies, which made up 3/4 of public spending in 2020/21 but were used by less than 8% of beneficiaries. Learn more at
0
0
0
@ODPRN_Research
ODPRN
7 months
NEW ODPRN study examined trends in the public spending of take-home cancer medications in Ontario from 2017 to 2021 and found that per-beneficiary spending rose by 32.8%. https://t.co/Sb77XJpX4j
odprn.ca
The cost and uptake of cancer medications dispensed as take-home treatments are not well understood. This study analyzed trends and the impact of COVID-19 on the utilization and cost of take-home...
1
0
0